1984
DOI: 10.1001/archopht.1984.01040030958024
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Glaucoma Using Minidrops of Clonidine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
4
0

Year Published

1987
1987
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(7 citation statements)
references
References 4 publications
1
4
0
Order By: Relevance
“…Ophthalmic timolol can cause symptomatic bradycardia, cardiac conduction disorders, orthostatic hypotension, and syncope and falls, particularly in geriatrics [29], and impairs pulmonary function in asthmatics [30]. Similarly, reducing the size of clonidine eyedrops (from 70 to 15 μl) in glaucomatous volunteers prevented the hypotensive effect that occurred with the larger drops [31]. Because these AEs are dose-dependent, microdosing of these and other ocular medications might reduce the likelihood of developing systemic side effects.…”
Section: Discussionmentioning
confidence: 39%
“…Ophthalmic timolol can cause symptomatic bradycardia, cardiac conduction disorders, orthostatic hypotension, and syncope and falls, particularly in geriatrics [29], and impairs pulmonary function in asthmatics [30]. Similarly, reducing the size of clonidine eyedrops (from 70 to 15 μl) in glaucomatous volunteers prevented the hypotensive effect that occurred with the larger drops [31]. Because these AEs are dose-dependent, microdosing of these and other ocular medications might reduce the likelihood of developing systemic side effects.…”
Section: Discussionmentioning
confidence: 39%
“…However, studies have shown that the drop in blood pressure is small and not significant clinically (Leydhecker 1974;Harrison 1977;Rozsival 1980). Other studies demonstrated that single dose treatment did not change blood pressure and heart rate significantly (Hodapp 1981), and in others the decrease in blood pressure was found to be caused only by clonidine 0.5%, and not by clonidine 0.25% (Petursson 1984). None of our patients experienced any clinically significant systemic hypotension.…”
Section: Discussionsupporting
confidence: 45%
“…With larger volumn eye drops, more medication passes into the nasolacrimal sac, increasing systemic absorption and the risk of toxicity (Shell 1982;Chrai et al 1973). It has been showed that decreasing the drop volume should not reduce efficacy (File & Patton 1980;Petursson et al 1984;Vocci et al 1992;Craig & Griffiths 1991). The smaller eyedrop volumes provoked less reflex lacrimation and permitted a slower lacrimal turnover than the larger volumes.…”
Section: Discussionmentioning
confidence: 99%